<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01438515</url>
  </required_header>
  <id_info>
    <org_study_id>2008-1265</org_study_id>
    <nct_id>NCT01438515</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization</brief_title>
  <official_title>Randomized Controlled Trial of Chlorhexidine Gluconate, Intranasal Mupirocin, Rifampin and Doxycycline Versus Chlorhexidine Gluconate and Intranasal Mupirocin Alone for the Eradication of Methicillin-resistant Staphylococcus Aureus Among an Ambulatory Patient Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Horizon Health Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Horizon Health Network</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MRSA decolonization may reduce the risk of subsequent MRSA infection and further
      transmission. A recent randomized controlled trial demonstrated that systemic decolonization
      may be safe and effective among hospitalized patients when compared to no treatment. As a
      large number of the investigators patients require re-admission and further transmission may
      take place in the community, the investigators are comparing the standard decolonization
      protocol for MRSA eradication to the systemic decolonization protocol among an ambulatory
      population.

      Standard decolonization protocols, which use only topical agents, are limited in efficacy.
      The method of systemic decolonization to be studied here appears to have greater efficacy
      than the standard approach using only topical agents. However, concerns have been raised that
      the increased use of systemic antibiotics may lead to increased levels of drug resistance
      adverse effects, without sustained decolonization. This study seeks to provide further data
      to help answer these questions and provide guidance for further policy development and
      implementation.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2008</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rates of sustained decolonization at 1 month, 3 months, 6 months and 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>To compare standard versus systemic decolonization for their ability to sustain MRSA decolonization up to one year post-decolonization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in susceptibility patterns of MRSA isolates.</measure>
    <time_frame>12 months</time_frame>
    <description>Study isolates will be evaluated with regards to mupirocin, rifampin and tetracycline resistance patterns, where individuals remain colonized, or re-colonize subsequent to implementation of the decolonization protocol.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Methicillin-resistant Staphylococcus Aureus</condition>
  <arm_group>
    <arm_group_label>Systemic decolonization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>7-day course of 4% chlorhexidine gluconate daily washes and 2% mupirocin ointment to the anterior nares twice daily in addition to oral rifampin (600mg daily), and doxycycline (100mg twice daily)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard decolonization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>7-day course of 2% mupirocin ointment to the anterior nares twice daily and 4% chlorhexidine gluconate washes once per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rifampin</intervention_name>
    <description>600mg po once daily x 7 days</description>
    <arm_group_label>Systemic decolonization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Doxycycline</intervention_name>
    <description>100mg po twice daily x 7 days</description>
    <arm_group_label>Systemic decolonization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2% mupirocin ointment</intervention_name>
    <description>~ 1cm applied to the anterior nares twice daily for 7 days</description>
    <arm_group_label>Systemic decolonization</arm_group_label>
    <arm_group_label>Standard decolonization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>4% chlorhexidine gluconate</intervention_name>
    <description>Daily full body wash (including hair) for 7 days</description>
    <arm_group_label>Systemic decolonization</arm_group_label>
    <arm_group_label>Standard decolonization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient colonized with MRSA

        Exclusion Criteria:

          -  Currently on treatment with antibiotics

          -  Pregnant or breastfeeding women

          -  Active infection

          -  Hepatic cirrhosis or abnormal INR due to liver disease

          -  Decolonization in the previous two (2) months

          -  MRSA bacteria resistant to one or more of the study medications

          -  AST and ALT levels more than five times the upper limit of normal.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Duncan Webster, MA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Horizon Health Network</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saint John Regional Hospital</name>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <zip>E2L4L2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin HR, Kiss A. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis. 2007 Jan 15;44(2):178-85. Epub 2006 Dec 14.</citation>
    <PMID>17173213</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2011</study_first_submitted>
  <study_first_submitted_qc>September 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2011</study_first_posted>
  <last_update_submitted>August 17, 2017</last_update_submitted>
  <last_update_submitted_qc>August 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Horizon Health Network</investigator_affiliation>
    <investigator_full_name>Duncan Webster</investigator_full_name>
    <investigator_title>Physician, Infectious Diseases and Medical Microbiology</investigator_title>
  </responsible_party>
  <keyword>MRSA</keyword>
  <keyword>doxycycline</keyword>
  <keyword>rifampin</keyword>
  <keyword>mupirocin</keyword>
  <keyword>chlorhexidine gluconate</keyword>
  <keyword>decolonization</keyword>
  <keyword>methicillin-resistant staphylococcus aureus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Staphylococcal Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Doxycycline</mesh_term>
    <mesh_term>Rifampin</mesh_term>
    <mesh_term>Methicillin</mesh_term>
    <mesh_term>Mupirocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

